OPALE, the Organization
for Partnerships in Leukemia
The OPALE Carnot institute is a healthcare industry’s preferred partner for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and first child cancer.
An unparalleled partnership offer
The OPALE Carnot Institute gives healthcare companies unique access to the expertise of an internationally unparalleled consortium in the field of leukemia and related diseases. Our aim is to prolong or save the lives of more patients by accelerating therapeutic and diagnostic innovation across the entire research and development value chain.
Explore our offer
Carnot, a label of excellence
Granted by the French Ministry of Higher Education, Research and Innovation, the Carnot label is prestigious and highly selective.
Being labelled Carnot is a guarantee of scientific and operational excellence in R&D collaborations for our industrial partners.
The Carnot institutes follow their namesake Charter to guarantee top-tier collaborative research, effectively driving industrial advancements while ensuring ongoing scientific revitalization within the Carnot community.
"The OPALE Carnot Institute addresses many of the needs of manufacturers in the leukemia market, thanks to the specialization and depth of its R&D offering, accessible through a one-stop shop."
Medical Director of a pharmaceutical company
Member of OPALE's Strategic Advisory Committee
"Accelerating the emergence of innovative solutions for the diagnosis, treatment, and follow-up of patients in the field of leukemia and related diseases"
Pr Hervé Dombret
OPALE's Chairman
News
Un partenariat inédit, lancé durant Septembre Rouge !
Sept. 30, 2024, 6:23 p.m.
Les instituts Carnot OPALE et CALYM et le Paris-Saclay Cancer Cluster s’associent pour accélérer la recherche en oncohématologie et soutenir l'innovation thérapeutique.
> Read moreLancement de l’appel à candidatures pour le programme OncoEntrepreneur 2024
Sept. 26, 2024, 12:15 p.m.
L’Institut Carnot OPALE et le PSCC ouvrent les candidatures pour le programme OncoEntrepreneur, dédié aux projets Healthtech en oncologie. Formation, accompagnement et networking au programme !
> Read moreWe are participating at OncoSTART alongside two spin-offs !
Sept. 24, 2024, 10:12 a.m.
First day of the OncoSTART Entrepreneurship School at Paris Saclay Cancer Cluster (PSCC) premises !
> Read more